![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|14|32|3417-3429
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.14, Iss.32, 2008-11, pp. : 3417-3429
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuroimaging of Serotonin System in Anxiety Disorders
Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting Functional Biomarkers in Schizophrenia with Neuroimaging
Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Economic Implications of Sleep Disorders
By Skaer Tracy L. Sclar David A.
PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)